These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 28252969

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Subcellular distribution of azithromycin and clarithromycin in rat alveolar macrophages (NR8383) in vitro.
    Togami K, Chono S, Morimoto K.
    Biol Pharm Bull; 2013; 36(9):1494-9. PubMed ID: 23995662
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
    Togami K, Chono S, Morimoto K.
    Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
    [Abstract] [Full Text] [Related]

  • 8. Quantitation of Lysosomal Trapping of Basic Lipophilic Compounds Using In Vitro Assays and In Silico Predictions Based on the Determination of the Full pH Profile of the Endo-/Lysosomal System in Rat Hepatocytes.
    Schmitt MV, Lienau P, Fricker G, Reichel A.
    Drug Metab Dispos; 2019 Jan; 47(1):49-57. PubMed ID: 30409837
    [Abstract] [Full Text] [Related]

  • 9. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
    Bauch C, Bevan S, Woodhouse H, Dilworth C, Walker P.
    Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
    Togami K, Chono S, Morimoto K.
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cellular accumulation and lipid binding of perfluorinated alkylated substances (PFASs) - A comparison with lysosomotropic drugs.
    Sanchez Garcia D, Sjödin M, Hellstrandh M, Norinder U, Nikiforova V, Lindberg J, Wincent E, Bergman Å, Cotgreave I, Munic Kos V.
    Chem Biol Interact; 2018 Feb 01; 281():1-10. PubMed ID: 29248446
    [Abstract] [Full Text] [Related]

  • 19. Identification of lysosomotropic compounds based on the distribution and size of lysosomes.
    Seo I, Jha BK, Lim JG, Suh SI, Suh MH, Baek WK.
    Biochem Biophys Res Commun; 2014 Jul 18; 450(1):189-94. PubMed ID: 24878535
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.